4 -乙酰氨基酚硫酸钾盐结构式
|
常用名 | 4 -乙酰氨基酚硫酸钾盐 | 英文名 | paracetamol sulfate potassium salt |
|---|---|---|---|---|
| CAS号 | 32113-41-0 | 分子量 | 269.31600 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C8H8KNO5S | 熔点 | 163ºC | |
| MSDS | 中文版 美版 | 闪点 | N/A | |
| 符号 |
GHS05, GHS07 |
信号词 | Danger |
| 中文名 | 4-乙酰氨基苯酚硫酸酯钾盐 |
|---|---|
| 英文名 | 4-Acetamidophenol sulfate ester potassium salt Acetaminophen sulfate |
| 中文别名 | 4-乙酰氨基酚硫酸钾盐 | 4-对乙酰氨基酚硫酸钾盐 |
| 英文别名 | 更多 |
| 熔点 | 163ºC |
|---|---|
| 分子式 | C8H8KNO5S |
| 分子量 | 269.31600 |
| 精确质量 | 268.97600 |
| PSA | 103.91000 |
| LogP | 1.63780 |
| 外观性状 | solid | white or off-white |
| 储存条件 | 2-8°C |
| 水溶解性 | H2O: soluble |
| 符号 |
GHS05, GHS07 |
|---|---|
| 信号词 | Danger |
| 危害声明 | H315-H317-H318-H335 |
| 警示性声明 | P261-P280-P305 + P351 + P338 |
| 个人防护装备 | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
| 危害码 (欧洲) | Xi: Irritant; |
| 风险声明 (欧洲) | 37/38-41-43 |
| 安全声明 (欧洲) | 26-36/37/39 |
| 危险品运输编码 | NONH for all modes of transport |
| WGK德国 | 3 |
| 海关编码 | 2924299090 |
|
~%
4 -乙酰氨基酚硫酸钾盐 32113-41-0 |
| 文献:Chemical Communications, , # 3 p. 314 - 316 |
|
~%
4 -乙酰氨基酚硫酸钾盐 32113-41-0 |
| 文献:Chemical Communications, , # 3 p. 314 - 316 |
| 4 -乙酰氨基酚硫酸钾盐上游产品 2 | |
|---|---|
| 4 -乙酰氨基酚硫酸钾盐下游产品 2 | |
| 海关编码 | 2924299090 |
|---|---|
| 中文概述 | 2924299090. 其他环酰胺(包括环氨基甲酸酯)(包括其衍生物以及他们的盐). 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:30.0% |
| 申报要素 | 品名, 成分含量, 用途, 包装 |
| Summary | 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
|
Immune thrombocytopenia resulting from sensitivity to metabolites of naproxen and acetaminophen.
Blood 97(12) , 3846-50, (2001) In patients suspected of having drug-induced immune thrombocytopenia, antibodies reactive with normal platelets in the presence of the suspect drug can sometimes be identified, but negative results ar... |
|
|
Simultaneous modelling of the Michaelis-Menten kinetics of paracetamol sulphation and glucuronidation.
Clin. Exp. Pharmacol. Physiol. 36(1) , 35-42, (2009) 1. The aim of the present study was to perform an in vivo estimation of the Michaelis-Menten constants of the major metabolic pathways of paracetamol (APAP). 2. A two-occasion, single-dose cross-over ... |
|
|
Simultaneous LC-MS/MS quantitation of acetaminophen and its glucuronide and sulfate metabolites in human dried blood spot samples collected by subjects in a pilot clinical study.
Bioanalysis 4(12) , 1429-43, (2012) In support of a pilot clinical trial using acetaminophen as the model compound to assess dried blood spot (DBS) sampling as the method for clinical pharmacokinetic sample collection, a novel sensitive... |
| potassium,(4-acetamidophenyl) sulfate |
| Paracetamol sulfate potassium salt |
| 4-AcetaminophenSulfatePotassiumSalt |